SAHPRA Pretoria Office currently operating remotely
Dear Stakeholders, Please be advised that the SAHPRA Pretoria Office is currently operating remotely...
08 September, 25
Looking for a document – search here:
News and Updates
-
-
SAHPRA Approves Mpox Test Using AMRH Continental EUL Procedure
Pretoria, 27 August 2025 –The South African Health Products Regulatory Authority (SAHPRA) has approv...
27 August, 25 -
SAHPRA attains clean audit outcome for the 2024/2025 financial year
Pretoria, 21 August 2025 – The South African Health Products Regulatory Authority (SAHPRA) is proud ...
21 August, 25 -
SAHPRA‘s position on anti-cancer medications in South Africa
Pretoria, 15 July 2025 – The South African Health Products Regulatory Authority (SAHPRA) was notifie...
15 July, 25
Media
Stay up to date with our latest news, media coverages, interviews and announcements on our Video Portal.
Databases and Registers
OTC Medicine Information
The Medicines’ Online Directory provides healthcare professionals and the consumer with a guide to all SAHPRA registered over-the counter (OTC) medicines that are available in South Africa without a doctor’s prescription.
Safety alerts
-
Warfarin and Tramadol – Harmful Drug-Drug Interaction
The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare prof...
06 June, 25 -
IV Tranexamic acid – Administration error via the intrathecal route
There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23 -
A Signal Of Myocarditis / Pericarditis Associated With Pfizer-biontech’s Covid-19 Vaccine, Comirnaty (Bnt162b2)
The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21 -
Risk of Drug-Induced Liver Injury associated with the use of Esbriet®
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20
Whistleblower
The hotline has been established with the aim of enhancing an honest work ethic and simultaneously providing the public with a mechanism to bring any unethical business practices to the attention of management.
Product Recalls
This recall is initiated because out of specification result observed for Assay of Propyl Parahydroxybenzoate (excipient) during routine stability testing of Vincristine Sulfate Injection.
The recall has been initiated due to a quality defect that may cause the needle to detach from the syringe body.
This recall is initiated due to contravention of Section 14 of the Medicines and Related Substances Act, 101 of 1965, as amended and contravention to the license conditions.
Social Media Feeds